Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Triple vessel stenting for triple vessel coronary disease.
Villegas B, Morice MC, Hernandez S, Choussat R, Dumas P, Lefevre T, Louvard Y, Loubeyre C, Fajadet J, Marco J. Villegas B, et al. Among authors: fajadet j. J Invasive Cardiol. 2002 Jan;14(1):1-5. J Invasive Cardiol. 2002. PMID: 11773686 Clinical Trial.
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R; RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. Morice MC, et al. Among authors: fajadet j. N Engl J Med. 2002 Jun 6;346(23):1773-80. doi: 10.1056/NEJMoa012843. N Engl J Med. 2002. PMID: 12050336 Free article. Clinical Trial.
Catheter-induced left main dissection: a treatment dilemma.
Mulvihill NT, Boccalatte M, Fajadet J, Marco J. Mulvihill NT, et al. Among authors: fajadet j. Catheter Cardiovasc Interv. 2003 Jun;59(2):214-6. doi: 10.1002/ccd.10481. Catheter Cardiovasc Interv. 2003. PMID: 12772243
Percutaneous treatment of coronary subclavian steal syndrome.
Mulvihill NT, Loutfi M, Salengro E, Boccalatte M, Laborde JC, Fajadet J, Marco J. Mulvihill NT, et al. Among authors: fajadet j. J Invasive Cardiol. 2003 Jul;15(7):390-2. J Invasive Cardiol. 2003. PMID: 12840236
High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial.
Grube E, Lansky A, Hauptmann KE, Di Mario C, Di Sciascio G, Colombo A, Silber S, Stumpf J, Reifart N, Fajadet J, Marzocchi A, Schofer J, Dumas P, Hoffmann R, Guagliumi G, Pitney M, Russell ME; SCORE randomized trial. Grube E, et al. Among authors: fajadet j. J Am Coll Cardiol. 2004 Oct 6;44(7):1368-72. doi: 10.1016/j.jacc.2004.06.054. J Am Coll Cardiol. 2004. PMID: 15464315 Free article. Clinical Trial.
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial.
Fajadet J, Morice MC, Bode C, Barragan P, Serruys PW, Wijns W, Constantini CR, Guermonprez JL, Eltchaninoff H, Blanchard D, Bartorelli A, Laarman GJ, Perin M, Sousa JE, Schuler G, Molnar F, Guagliumi G, Colombo A, Ban Hayashi E, Wülfert E. Fajadet J, et al. Circulation. 2005 Mar 1;111(8):1040-4. doi: 10.1161/01.CIR.0000156334.24955.B2. Epub 2005 Feb 21. Circulation. 2005. PMID: 15723977 Free article. Clinical Trial.
266 results